{"name":"Mustang Bio","slug":"mustang-bio","ticker":"MBIO","exchange":"NASDAQ","domain":"mustangbio.com","description":"Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency (X-SCID).","hq":"Worcester, MA","founded":0,"employees":"","ceo":"Manuel Litchman","sector":"Cell & Gene Therapy","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$45M","metrics":{"revenue":2000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":2100000,"netIncome":-1921000,"cash":17266000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"MB-106 patent cliff ($0.0B at risk)","drug":"MB-106","type":"patent_expiry","sentiment":"negative"},{"date":"2035-06-01","label":"MB-102 patent cliff ($0.0B at risk)","drug":"MB-102","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-16","type":"regulatory","headline":"Mustang Bio Announces FDA Clearance of Investigational New Drug (IND) Application for MB-106","summary":"Mustang Bio announced that the FDA has cleared the IND application for MB-106, a CAR-T cell therapy for the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma.","drugName":"MB-106","sentiment":"neutral"},{"date":"2022-11-14","type":"deal","headline":"Mustang Bio Announces Collaboration with Cellectis to Develop Allogeneic CAR-T Cell Therapies","summary":"Mustang Bio announced a collaboration with Cellectis to develop allogeneic CAR-T cell therapies for the treatment of cancer.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1IX1BBenhvS3gxaDZFUVRPdFFGY3BWcjNYTmdMenVLOG9tY2oxNG5aMXBoNVM3dWZ5TXNsQU9jRzZ5ZHRaOWhIZW1uOXdZdVAxRnROSzFLUjdRQ1Y0YTl4X1ZweENQbTFCYm5GUG9B?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Mustang Bio (MBIO) - Stock Titan","headline":"If You Invested $1,000 in Mustang Bio (MBIO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZUVA3bC1ELURxcUNyMG1wb2xORElEaWxfdmFPdmdUeVdVUGFva3BwY0FpeFlZRXdFTXJEc2xNQk1xbW5lSU1BV2l4WlFnTFh1QjE4M1YxVDdHRWN2X2Y4?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"MBIO Stock Price, Quote & Chart | MUSTANG BIO INC (NASDAQ:MBIO) - ChartMill","headline":"MBIO Stock Price, Quote & Chart | MUSTANG BIO INC (NASDAQ:MBIO)","sentiment":"neutral"},{"date":"2026-03-19","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPMm5YNEUzcUZnY1Q5VFZMUU1HcWd4Vzh0eDU0SnV0eERKQU5TSmNXQ09xVzZ1WFpQQ0NQN0tVS2ZZSTJrZjBEWlNuTVJvSGliR1lHdHB5MjQ1d1hCZ2xQZWFPQk90YmV5UkM2aUh4Rlp2VjNkNElFaGx4akFTSGxJZDNycVo2ZVpRaWJvSlBKZHZfSkxuSXJNRFFudzMxLWxYTHc0c25LOU9QaDhmUEdGSHhhekM?oc=5","date":"2026-02-06","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Pre-Market Session","sentiment":"neutral"},{"date":"2025-12-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-08","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-07-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFA3MUx2c1hZZUJaRzhIZWRTcnl4SU1VYWpXT25ScGlpNGdleVQ4Z3lEeG81b2hHYmhiaktWN1V0VkVYSXJ2QktSTXNRU3g1RjJta2RuVEYxRlVVYUhRanpfbUNwcHlPdFBKZ2pWUW9DcUlVSXI0dUVGUXA1Wkw?oc=5","date":"2025-07-08","type":"pipeline","source":"Yahoo Finance","summary":"MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - Yahoo Finance","headline":"MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy","sentiment":"neutral"},{"date":"2025-05-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ndGJPNng3RS1wOUNpRG1CckNUZWI0VXlGQ1Z6YmktYUxxbGxyY0NOMWlVRHFBMGZrMHRNRXVjTjdXb2Vfcllxd1pzMlE4NmZ1NU5EZnE1NHg3WEFrUUpN?oc=5","date":"2021-11-05","type":"deal","source":"The Stock Dork","summary":"The 9 Best Biotech Penny Stocks to Buy For %currentmonth% %currentyear%! - The Stock Dork","headline":"The 9 Best Biotech Penny Stocks to Buy For %currentmonth% %currentyear%!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPek9RcF9aNXRmMlZFZjRlVG5rNVEzMW9vdVVjV2Z2ZEJLdVVYMEJJamVUcEJPYVFnMmM1ZVROY1ctWEJ2QTFpWmVYemVnS211dHgwcVRyOEFJdGVDUFhZSFUyWTJwRmdtUDdtQVFIbFFKQjBZNFEwTC1PckFnZ1djVnhOaEdkejQ?oc=5","date":"2021-02-07","type":"deal","source":"InvestorPlace","summary":"7 Penny Stocks That Actually Have Buy Ratings - InvestorPlace","headline":"7 Penny Stocks That Actually Have Buy Ratings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTFBvNmt1djRaSnFIS0FkN0dCUVFITzk2TXpFSVk4T1ZCeXZoMnliSWR1T2NWZ2FsMF8ycFl4UU5JQnFpNlA4bW91cA?oc=5","date":"2020-12-01","type":"deal","source":"StockInvest.us","summary":"Mustang Bio Stock Price Forecast. Should You Buy MBIO? - StockInvest.us","headline":"Mustang Bio Stock Price Forecast. Should You Buy MBIO?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhVDJLbThhZFZici1nRUFRSjBsMXdXZVNDMFRtNGFRbnB5S1RlR3pFYnpmLWZWY3BEcGo1dmJydk9yU2dFeTF2Qmdidm50THFDYW1SWi1wTFB2dw?oc=5","date":"2017-11-09","type":"pipeline","source":"MarketBeat","summary":"Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat","headline":"Mustang Bio (MBIO) Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFB4VzktczZOcllMOEFNcnZPOXRzMUo2U1RqUzVBMWJWT05sTmVyOXB4bG1ydGhlUm5XbHE3dmhhaENRMlZYcTVpYkV2WHg0MjFEUUE?oc=5","date":"2017-09-09","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Mustang Bio, Inc. (MBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Mustang Bio, Inc. (MBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"}],"patents":[{"drugName":"MB-106","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0},{"drugName":"MB-102","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2035-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["CRISPR Therapeutics","Editas Medicine","Bluebird Bio"],"therapeuticFocus":["Oncology","Hematological Malignancies"],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":0,"period":"2019-12-31"},{"value":0,"period":"2019-09-30"},{"value":0,"period":"2019-06-30"},{"value":0,"period":"2019-03-31"},{"value":-50000,"period":"2018-12-31"},{"value":0,"period":"2018-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":2100000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-1921000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":17266000,"cashHistory":[],"totalAssets":17593000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}